Z

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357

Watchlist Manager
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357
Watchlist
Price: 21.28 CNY -1.07%
Market Cap: 11.1B CNY
Have any thoughts about
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

Current Assets 1.6B
Cash & Short-Term Investments 1.3B
Receivables 263.5m
Other Current Assets 66.7m
Non-Current Assets 1B
Long-Term Investments 78.5m
PP&E 757m
Intangibles 183.9m
Other Non-Current Assets 13.9m
Current Liabilities 248.6m
Accounts Payable 7.6m
Accrued Liabilities 23.9m
Short-Term Debt 44.4m
Other Current Liabilities 172.8m
Non-Current Liabilities 190.1m
Long-Term Debt 17.7m
Other Non-Current Liabilities 172.4m

Balance Sheet
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2023
Assets
Cash & Cash Equivalents
103
276
272
235
186
460
751
584
650
1 171
Cash
0
0
0
0
0
0
0
0
280
1 171
Cash Equivalents
103
276
272
235
186
460
751
584
370
0
Short-Term Investments
0
0
0
0
0
0
41
307
371
117
Total Receivables
78
99
102
117
146
173
216
227
260
216
Accounts Receivables
59
62
65
77
102
109
134
134
156
143
Other Receivables
19
37
37
40
45
65
83
92
104
73
Inventory
8
12
9
14
20
24
37
48
54
59
Other Current Assets
6
61
101
173
304
125
5
5
7
6
Total Current Assets
195
447
484
539
657
782
1 050
1 171
1 342
1 570
PP&E Net
48
60
97
119
124
138
198
240
302
716
PP&E Gross
48
60
97
119
124
138
198
240
302
716
Accumulated Depreciation
18
21
25
19
24
30
38
50
67
108
Intangible Assets
19
22
28
37
53
123
161
170
176
188
Long-Term Investments
0
0
0
0
13
13
13
14
83
74
Other Long-Term Assets
1
2
3
2
2
2
7
9
29
13
Total Assets
264
N/A
531
+101%
612
+15%
697
+14%
848
+22%
1 058
+25%
1 428
+35%
1 605
+12%
1 932
+20%
2 562
+33%
Liabilities
Accounts Payable
1
1
1
1
1
3
9
6
5
8
Accrued Liabilities
3
4
5
8
12
15
20
23
36
34
Short-Term Debt
0
0
0
0
0
0
0
0
0
34
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
6
7
Other Current Liabilities
8
11
19
27
29
40
32
27
62
94
Total Current Liabilities
12
16
25
37
42
58
60
55
108
177
Long-Term Debt
0
0
0
0
0
0
0
0
2
21
Deferred Income Tax
0
0
0
0
0
0
0
1
0
0
Minority Interest
0
0
0
0
0
26
81
72
61
119
Other Liabilities
0
2
4
5
5
5
16
21
25
60
Total Liabilities
12
N/A
18
+48%
29
+61%
41
+44%
47
+14%
88
+88%
157
+78%
149
-5%
196
+32%
377
+92%
Equity
Common Stock
90
162
162
162
162
291
524
524
524
524
Retained Earnings
162
170
240
312
458
626
619
803
1 084
1 533
Additional Paid In Capital
0
182
182
182
182
52
128
128
128
128
Other Equity
0
0
0
0
0
0
0
1
0
0
Total Equity
252
N/A
514
+104%
583
+13%
656
+12%
801
+22%
970
+21%
1 271
+31%
1 456
+15%
1 736
+19%
2 185
+26%
Total Liabilities & Equity
264
N/A
531
+101%
612
+15%
697
+14%
848
+22%
1 058
+25%
1 428
+35%
1 605
+12%
1 932
+20%
2 562
+33%
Shares Outstanding
Common Shares Outstanding
467
524
524
524
524
524
524
524
524
524

See Also

Discover More